Capricor Therapeutics
CAPR
#5617
Rank
HK$10.93 B
Marketcap
HK$188.88
Share price
1.18%
Change (1 day)
142.37%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of March 2026 : HK$2.18 Billion

According to Capricor Therapeutics 's latest financial reports the company has HK$2.18 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2024-12-31$HK$1.12 B539.76%
2023-12-31$HK$0.17 B91.69%
2022-12-31$HK$92.08 M-62.35%
2021-12-31$HK$0.24 B11.89%
2020-12-31$HK$0.21 B310.41%
2019-12-31$HK$53.26 M47.37%
2018-12-31$HK$36.14 M-58.79%
2017-12-31$HK$87.71 M-382.56%
2016-12-31$-HK$31.05 Million288.18%
2015-12-31$-HK$8 Million-83.5%
2014-12-31$-HK$48.47 Million1068.56%
2013-12-31$-HK$4.15 Million-110.93%
2012-12-31$HK$37.93 M487.99%
2011-12-31$HK$6.45 M-68.07%
2010-12-31$HK$20.2 M-12.6%
2009-12-31$HK$23.12 M-41.37%
2008-12-31$HK$39.43 M-66.72%
2007-12-31$HK$0.11 B-11406.03%
2006-12-31$-HK$1.05 Million74.17%
2005-12-31$-HK$0.61 Million31.79%
2004-12-31$-HK$0.46 Million44.8%
2003-12-31$-HK$0.32 Million64.86%
2002-12-31$-HK$0.2 Million174.34%
2001-12-31$-HK$0.07 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
HK$636.79 B 29,029.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$26.72 B 1,122.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$6.49 Billion-396.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$3.57 B 63.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$3.1 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$28 M-98.72%๐Ÿ‡บ๐Ÿ‡ธ USA